Lakefront Biotherapeutics NV Stock
Stocks
LKFT
BE0003818359
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Euronext Amsterdam
11:55:00 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 23.90 EUR | -1.65% |
|
+2.40% | -14.64% |
| Market Cap | 1.57B 1.82B 1.48B 1.35B 2.53B 174B 2.57B 17.34B 6.78B 87.32B 6.85B 6.7B 290B | P/E 2026 * |
-11.2x | P/E 2027 * | -8.46x |
|---|---|---|---|---|---|
| Enterprise Value | -482M -558M -453M -412M -774M -53.36B -787M -5.31B -2.07B -26.72B -2.1B -2.05B -88.8B | EV / Sales 2026 * |
-18x | EV / Sales 2027 * | -8.89x |
| Free-Float |
-
| Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Lakefront Biotherapeutics NV
| 08-12 | Acquisition of Own Shares | GL |
| 08-10 | Lakefront Biotherapeutics Reports Half-Year 2026 Financial Results and Provides Business Update | GL |
| 08-04 | Acquisition of Own Shares | GL |
| 07-28 | Acquisition of Own Shares | GL |
| 07-21 | Acquisition of Own Shares | GL |
| 1 day | -1.65% | ||
| 1 week | +2.40% | ||
| Current month | +0.17% | ||
| 1 month | -7.22% | ||
| 3 months | +2.14% | ||
| 6 months | -15.73% | ||
| Current year | -14.64% |
| 1 week | 22.46 |  | 25 |
| 1 month | 22.32 | | 26.46 |
| Current year | 22.32 | | 30.72 |
| 1 year | 22.32 | | 32.74 |
| 3 years | 20 | | 39 |
| 5 years | 20 | | 66.28 |
| 10 years | 20 | | 252.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Henry Gosebruch
CEO | Chief Executive Officer | 53 | 2025-05-11 |
Aaron Cox
DFI | Director of Finance/CFO | 41 | 2025-07-06 |
| Chief Operating Officer | - | 2026-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Linda Higgins
BRD | Director/Board Member | 63 | 2019-10-21 |
Oleg Nodelman
BRD | Director/Board Member | 49 | 2024-10-06 |
Henry Gosebruch
BRD | Director/Board Member | 53 | 2025-05-11 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/28/26 | Buy | Director | 137 | 0.0002% | ||
| 1/28/26 | Buy | Director | 375 | 0.0006% | ||
| 1/28/26 | Free | General Counsel | 235,000 | 0.3566% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.65% | +2.40% | -13.34% | -33.57% | 1.82B | |
| -1.78% | -1.68% | +1.48% | +15.31% | 48.42B | |
| +0.85% | -0.70% | +460.88% | +563.55% | 43.66B | |
| -2.40% | -0.23% | +8.13% | +71.41% | 39.51B | |
| -2.01% | -0.85% | +23.85% | +8.73% | 38.95B | |
| -0.50% | +0.85% | +20.60% | +49.65% | 32.61B | |
| +0.38% | -3.23% | - | - | 16.32B | |
| -0.59% | -2.06% | +26.35% | +118.09% | 16.15B | |
| +0.49% | +0.92% | +4.11% | +23.67% | 14.16B | |
| -0.43% | +4.70% | +78.74% | +33.31% | 13.37B | |
| Average | -0.76% | +0.68% | +67.87% | +94.46% | 26.5B | |
| Weighted average by Cap. | -0.92% | +0.60% | +95.03% | +131.73% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 26.71M 30.93M 25.1M 22.83M 42.92M 2.96B 43.62M 294M 115M 1.48B 116M 114M 4.92B | 53.46M 61.9M 50.24M 45.69M 85.9M 5.92B 87.31M 589M 230M 2.96B 232M 227M 9.85B |
| Net income | 44.95M 52.04M 42.24M 38.41M 72.22M 4.98B 73.41M 495M 194M 2.49B 195M 191M 8.28B | -113M -130M -106M -96.24M -181M -12.47B -184M -1.24B -485M -6.24B -490M -479M -20.75B |
| Net Debt | -2.06B -2.38B -1.93B -1.76B -3.3B -228B -3.36B -22.65B -8.85B -114B -8.94B -8.75B -379B | -2.05B -2.37B -1.93B -1.75B -3.29B -227B -3.35B -22.57B -8.83B -114B -8.91B -8.72B -378B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-14 | €23.90 | -1.65% | 68,150 |
| 26-08-13 | €24.30 | -0.57% | 93,285 |
| 26-08-12 | €24.44 | +0.41% | 228,780 |
| 26-08-11 | €24.34 | +3.84% | 222,871 |
| 26-08-10 | €23.44 | +0.43% | 100,415 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LKFT Stock
Select your edition
All financial news and data tailored to specific country editions
